The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Estradiol (NDC 70771-1400). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1400-4
Estradiol Transdermal System, USP
0.014 mg/day
Apply one transdermal system per week.
For Transdermal Use Only
Contents: 4 Transdermal Systems
Rx Only
zydus Pharmaceuticals USA
Estradiol Transdermal System Usp 0.014 mg (7287c5b3 80de 4eab 9905 F597a4fbaf34 01)
* Please review the disclaimer below.
